Cargando…

Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing

Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving de novo synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyd, Natalie K., Teng, Chengwen, Frei, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165386/
https://www.ncbi.nlm.nih.gov/pubmed/34079770
http://dx.doi.org/10.3389/fcimb.2021.684515
_version_ 1783701310729617408
author Boyd, Natalie K.
Teng, Chengwen
Frei, Christopher R.
author_facet Boyd, Natalie K.
Teng, Chengwen
Frei, Christopher R.
author_sort Boyd, Natalie K.
collection PubMed
description Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving de novo synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may have repurposing potential, either alone or in combination with an antibiotic. They might also serve as “antibiotic adjuvants” to enhance the activity of certain antibiotics.
format Online
Article
Text
id pubmed-8165386
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81653862021-06-01 Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing Boyd, Natalie K. Teng, Chengwen Frei, Christopher R. Front Cell Infect Microbiol Cellular and Infection Microbiology Drug repurposing, or identifying new uses for existing drugs, has emerged as an alternative to traditional drug discovery processes involving de novo synthesis. Drugs that are currently approved or under development for non-antibiotic indications may possess antibiotic properties, and therefore may have repurposing potential, either alone or in combination with an antibiotic. They might also serve as “antibiotic adjuvants” to enhance the activity of certain antibiotics. Frontiers Media S.A. 2021-05-17 /pmc/articles/PMC8165386/ /pubmed/34079770 http://dx.doi.org/10.3389/fcimb.2021.684515 Text en Copyright © 2021 Boyd, Teng and Frei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Boyd, Natalie K.
Teng, Chengwen
Frei, Christopher R.
Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
title Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
title_full Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
title_fullStr Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
title_full_unstemmed Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
title_short Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing
title_sort brief overview of approaches and challenges in new antibiotic development: a focus on drug repurposing
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165386/
https://www.ncbi.nlm.nih.gov/pubmed/34079770
http://dx.doi.org/10.3389/fcimb.2021.684515
work_keys_str_mv AT boydnataliek briefoverviewofapproachesandchallengesinnewantibioticdevelopmentafocusondrugrepurposing
AT tengchengwen briefoverviewofapproachesandchallengesinnewantibioticdevelopmentafocusondrugrepurposing
AT freichristopherr briefoverviewofapproachesandchallengesinnewantibioticdevelopmentafocusondrugrepurposing